Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin‐17 Signalling and Poly(I:C)‐Induced Lung Inflammation in BALB/c Mice
Basic & Clinical Pharmacology & Toxicology · 2026-08 · 139 (2)
DOI: 10.1111/bcpt.70272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 10.07.2026. Verfasst von Eda Nur İnkaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hacettepe University, Department of Biology, Faculty of Science, Ankara, Turkey. Hauptthemen laut MEDLINE: Fluorocarbons, Interleukin-17, Alkanesulfonic Acids, Caprylates. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Council of Higher Education (YÖK), Scientific and Technological Research Council of Türkiye (TÜBİTAK), Scientific Research Projects Coordination Unit of Hacettepe University.
Abstract (Originalsprache)
The aim of this study was to investigate the effects of co‐exposure to perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on the IL‐17‐related immune responses and the Poly(I:C)‐induced lung inflammation. A total of 66 adult male BALB/c mice were divided into 11 groups, including controls, dose groups receiving PFOS+PFOA (1, 3, 9 mg/kg/day), and combination groups challenged with intratracheal Poly(I:C). Immunological responses were evaluated using flow cytometry, RT‐qPCR and ELISA assays. Poly(I:C) stimulation increased Th1, Th17 and Th22 cell percentages, consistent with immune activation. PFOS+PFOA exposure attenuated these responses in a dose‐dependent manner under Poly(I:C) (+) conditions. Conversely, increased Th2 cell percentages were observed in PFOS+PFOA exposure groups. Gene expression analyses of Stat3 , Il17ra and Ror‐γt further suggested tissue‐level modulation of IL‐17‐related signalling pathways. Overall, PFOS+PFOA exposure may modulate the pulmonary immune microenvironment and alter Th1/Th17/Th22‐associated responses to Poly(I:C)‐induced inflammatory stimulation. These findings suggest that PFAS mixtures may influence pulmonary immune regulation under inflammatory conditions and support the inclusion of immune endpoints in PFAS toxicological evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hacettepe University, Department of Biology, Faculty of Science, Ankara, Turkey.
ORCID-Profile: Eda Nur İnkaya, Seçil Karahisar Turan, Nurhayat Barlas
Förderung
- Council of Higher Education (YÖK)
- Scientific and Technological Research Council of Türkiye (TÜBİTAK)
- Scientific Research Projects Coordination Unit of Hacettepe University
- Yükseköğretim Kurulu
Zitieren
APA
İnkaya, E. N., Karahisar Turan, S., & Barlas, N. (2026). Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin‐17 Signalling and Poly(I:C)‐Induced Lung Inflammation in BALB/c Mice. Basic & Clinical Pharmacology & Toxicology, 139(2). https://doi.org/10.1111/bcpt.70272
Vancouver
İnkaya EN, Karahisar Turan S, Barlas N. Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin‐17 Signalling and Poly(I:C)‐Induced Lung Inflammation in BALB/c Mice. Basic & Clinical Pharmacology & Toxicology. 2026;139(2). doi:10.1111/bcpt.70272
BibTeX
@article{nkaya2026,
author = {İnkaya, Eda Nur and Karahisar Turan, Seçil and Barlas, Nurhayat},
title = {Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin‐17 Signalling and Poly(I:C)‐Induced Lung Inflammation in BALB/c Mice},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2026},
volume = {139},
number = {2},
doi = {10.1111/bcpt.70272}
}
EUVIMED